Data protection Impressum

Biotech

ADM is strengthening its innovation footprint in Western Switzerland with a new R&D center focused on microbiomes to support animal health. The center is located at the Biopôle in Lausanne.

ADM opens new R&D center at Biopôle to advance animal microbiome science

30 June 2025

Superlab Suisse will open a new laboratory at Campus Biotech in Geneva in January 2026, strengthening the region’s innovation infrastructure for life sciences start-ups.

Superlab expands to Geneva with new lab at Campus Biotech

25 June 2025

Launched in Hamburg, the ORYL F1 marks a new milestone for EPFL spin-off ORYL Photonics, combining speed, precision, and sustainability for drug development.

ORYL Photonics launches breakthrough solubility and aggregation measurement platform

24 June 2025

Biotech KYLYS Aesthetics has raised CHF 1 million to advance clinical development of its next-generation hyaluronic acid medical devices for regenerative aesthetic medicine.

Geneva-based KYLYS raises CHF 1 million to advance regenerative aesthetic medicine

23 June 2025

At the crossroads of tradition and innovation, the University of Fribourg’s Section of Medicine offers a distinct vision for the future of healthcare. As part of Switzerland’s only fully bilingual university, the Section of Medicine is advancing both education and translational research in a collaborative, human-focused environment.

The University of Fribourg’s human-centered approach to medicine

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (May 2025)

28 May 2025

In the heart of Fribourg, the Adolphe Merkle Institute (AMI) has grown into a globally recognized center of excellence in materials science. Founded in 2008 through the visionary endowment of Swiss entrepreneur Dr. Adolphe Merkle, the institute was built on a simple yet powerful belief: fundamental science can bridge the gap to real-world impact.

Adolphe Merkle Institute: Where science meets application in the heart of Fribourg

Western Switzerland is rapidly becoming a hotspot for biomanufacturing and life sciences companies, thanks to its strong infrastructure, skilled talent, and business-friendly policies. Yassin Nahi, GGBa (Greater Geneva Bern area) Life Science Director, shares how the region's research hubs, academic institutions, and regulatory support make it an ideal location for companies in this sector.

Why Western Switzerland for Biomanufacturing and Life Sciences Companies: an interview with expert Yassin Nahi

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Lausanne-based biotech ReproNovo has secured USD 65 million to advance Phase 2 trials for novel therapies in male infertility and women’s reproductive health.

ReproNovo raises USD 65 million to advance trials in reproductive health

21 May 2025

1 2 3 4 5 6 7 8 … 24